Bulls vs Bears
Click to unlock major analysts' bullish and bearish positions by joining Benzinga Edge.
Benzinga Rankings give you vital metrics on any stock – anytime.
You can purchase shares of CRISPR Therapeutics (NASDAQ:CRSP) through any online brokerage.
Other companies in CRISPR Therapeutics’s space includes: Immunovant Inc (NASDAQ:IMVT), Cogent Biosciences Inc (NASDAQ:COGT), Celcuity Inc (NASDAQ:CELC), Centessa Pharmaceuticals PLC (NASDAQ:CNTA) and Alkermes PLC (NASDAQ:ALKS).
CRISPR Therapeutics has a consensus price target of $72.24.
The stock price for CRISPR Therapeutics (NASDAQ: CRSP) is $56.2 last updated March 6, 2026 at 7:02 PM EST.
There are no upcoming dividends for CRISPR Therapeutics.
CRISPR Therapeutics does not have any upcoming earnings scheduled.
There is no upcoming split for CRISPR Therapeutics.
CRISPR Therapeutics is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.